Liquid biopsy is minimally invasive diagnostic procedure alternative to surgical biopsies. Liquid biopsy helps in collection of a wide range of information about a cancer/tumor through a simple blood sample. The procedure can help in exact detection of mutations in epidermal growth factor receptors in cancers such Non-Hodgkin’s Lymphoma (NSCLC). Furthermore, identification of traces of the cancer’s DNA in the blood could help in administration of precision treatments that could increase the ... Read more

Market Research Future adds new report of “Global Liquid biopsy market by type from 2013 to 2022” it contains Company information, geographical data.

Global Liquid biopsy Market by application is projected to grow at a CAGR of 28.0% and is expected to reach US$ 17,372.28 million by 2022. Globally, the North America accounted for the largest market share in 2016.

Global Liquid biopsy is one of the fastest market. The liquid biopsy technique provides a ... Read more

The Liquid Biopsy Market is estimated to be valued at Us$ 13,220 Mn in 2022 and is expected to exhibit a CAGR Of 4.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Liquid biopsy is a non-invasive blood test for detecting various types of cancer in the body. It allows doctors to obtain sample of tumor DNA circulating in the ... Read more